POTENTIAL BIOACTIVITY OF CURCUMIN WITH CHITOSAN NANOENCAPSULATION AS A HOST-DIRECTED APPROACH FOR ADVANCED HERBAL THERAPY OF TUBERCULOSIS IN INDONESIA
Herbal Utilization as Adjuvant Therapy in Antibiotic-Dependent Infectious Diseases
DOI:
https://doi.org/10.53366/jimki.v10i3.758Keywords:
HDT, Chitosan, Curcumin, Nanoencapsulation, TuberculosisAbstract
Background: Tuberculosis (TB) is a deadly tropical infectious disease caused by Mycobacterium tuberculosis (MTB). The combination of antibiotics as the current TB management raises new problems such as high rates of drug resistance and serious adverse effects on the liver. Alternative therapies that are effective, safe, and affordable in treating TB are needed.
Discussion: One of the therapeutic approaches that can be used to avoid bacterial resistance is Host-Directed Therapy (HDT) because it utilizes the host's capabilities. Curcumin is a yellow-colored polyphenol pigment that has a variety of beneficial pharmacological effects including anti-tuberculosis effects through its modulation of the human immune system so that it can be one of the HDTs. However, curcumin still has the major disadvantage of decreased pharmacokinetics because it is easily degraded and its oral bioavailability is poor. To improve its performance, curcumin can be combined with nanoencapsulation agent, chitosan. Curcumin is proven to have the ability to work as Host-Directed Therapy from various studies. Curcumin can inhibit the growth of MTB intracellularly while inducing apoptosis in MTB-infected cells. Nanoencapsulation using chitosan is proven in various trials to improve the pharmacokinetic profile and bioavailability of curcumin so that its performance becomes better. The use of curcumin with chitosan nanoencapsulation in Indonesia is very possible because both agents are very easy to produce domestically and have a relatively affordable price.
Conclusion: Nanoencapsulation of herbal curcumin by chitosan has the potential to be an effective, safe, and affordable cutting-edge therapeutic modality in treating tuberculosis in Indonesia.
Keywords: HDT, Chitosan, Curcumin, Nanoencapsulation, Tuberculosis
Downloads
Published
Issue
Section
License
Copyright (c) 2025 JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
Similar Articles
- Alfi Rahmatika, Muhammad Mufaiduddin, Innelya Innelya, The Potency of CtpF in Mycobacterium tuberculosis in The Development of CtpF-Inhibitors as Innovative Target Therapy in MDR/DR TB Treatment , JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia: Vol. 10 No. 1 (2022): JIMKI (Jurnal Ilmiah Mahasiswa Kedokteran Indonesia) Volume 10 Nomor 1 Periode Maret-September 2022
- Surya Wijaya, Muthmainnah Arifin, Analisis Potensi Curcumin Kunyit (Curcuma longa) Sebagai Agen Neuroproktektor, Antiinflamasi, dan Antioksidan , JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia: Vol. 1 No. 2 (2012): JIMKI : Jurnal Ilmiah Mahasiswa Kedokteran Indonesia
- Fadlan Hafizh Harahap, THE ASSOCIATION BETWEEN TUBERCULOSIS RISK FACTORS AND VITAMIN D SERUM LEVEL ON TUBERCULOSIS PATIENS , JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia: Vol. 9 No. 3 (2022): JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia Volume 9.3 Edisi Desember 2021-April 2022
- Ayunda Pratiwi L. Tobing, Ance Roslina, Factors Of AFB Conversion In Patients With Pulmunonary Tuberculosis In Haji Medan General Hospital , JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia: Vol. 8 No. 3 (2021): JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia Volume 8.3 Edisi September 2020 - Februari 2021
- Jaya Firmansyah, Hana Nafisah, Nabila Rayhan Yasmin, DNA HEAT SHOCK PROTEIN 65 (HSP65) VACCINE WITH NANOPARTICLE PLGA ENCRYPTED KLK AS A PREVENTIVE AND CURATIVE TUBERCULOSIS THERAPY INNOVATION , JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia: Vol. 9 No. 2 (2021): JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia Volume 9.2 Edisi Agustus - November 2021
- Caroline Ciptasari, Mario Steffanus, Stefanus Lembar, Decreased Neutrophil to Lymphocyte Ratio in Tuberculosis Patients After Intensive Therapy , JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia: Vol. 6 No. 1 (2018): JIMKI : Jurnal Ilmiah Mahasiswa Kedokteran Indonesia Volume 6.1 Edisi April - September 2018
- R.Merlinda Veronica, Abdurrahman Azis, R.Melda Indri, Arya Marganda Simanjuntak, MILIARY TUBERCULOSIS AND ELEVATED TRANSAMINASE ENZYMES IN AN UNTREATED HUMAN IMMUNIDEFICIENCY VIRUS (HIV) PATIENT: A CASE REPORT , JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia: Vol. 10 No. 2 (2023): Vol 10 No 2 (2023): JIMKI (Jurnal Ilmiah Mahasiswa Kedokteran Indonesia) Volume 10 Nomor 2 Periode Oktober 2022-April 2023
- Belva Bhadranitya Buana, BEDAQUILINE AS A MANAGEMENT OF MULTIDRUG-RESISTANT TUBERCULOSIS (MDR-TB): A SYSTEMATIC REVIEW AND META ANALYSIS , JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia: Vol. 10 No. 2 (2023): Vol 10 No 2 (2023): JIMKI (Jurnal Ilmiah Mahasiswa Kedokteran Indonesia) Volume 10 Nomor 2 Periode Oktober 2022-April 2023
- Nabil Athoillah, Ditya Pramudyaning Tias, Ichlasul Mahdi Fardhani, Setiadi Drajad Kurniawan, TUBERCULOSIS PATTERN ON CHEST X-RAY OF A 16-YEAR-OLD FEMALE WITH DROWNING-RELATED ASPIRATION PNEUMONIA IN ENDEMIC COUNTRY, INDONESIA: A CASE REPORT , JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia: Vol. 11 No. 2 (2025): JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia Vol. 11.2 (2025)
- Surya Wijaya, POTENSI PEMANFAATAN GREEN TEA-DERIVED POLYPHENOLS (GTPS) TEH HIJAU (CAMELLIA SINENSIS) SEBAGAI INOVASI PENGEMBANGAN TERAPI ADJUVAN PADA PASIEN TUBERKULOSIS , JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia: Vol. 2 No. 2 (2014): JIMKI : Jurnal Ilmiah Mahasiswa Kedokteran Indonesia
You may also start an advanced similarity search for this article.